Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
473 studies found for:    Open Studies | "neurological disorders"OR"brain tumors"OR"attention-deficit/hyperactivity disorder"OR"epilepsy"OR"chronic pain"OR"spincal cord injury"OR"stroke" | United States | Phase 1, 2, 3, 0 | Industry
Show Display Options
Download search resultsDownload the search results for:
Open Studies | "neurological disorders"OR"brain tumors"OR"attention-deficit/hyperactivity disorder"OR"epilepsy"OR"chronic pain"OR"spincal cord injury"OR"stroke" | United States | Phase 1, 2, 3, 0 | Industry (473 records)
Download Content:
zip file readers with free trial periods: WinZip and PKZip
Rank Status Study
1 Recruiting MRI-Guided Focused Ultrasound Feasibility Study for Brain Tumors
Condition: Brain Tumor
Intervention: Device: ExAblate transcranial system
2 Recruiting Photodynamic Therapy (PDT) for Recurrent Pediatric Brain Tumors
Condition: Brain Tumor, Recurrent
Intervention: Drug: Photofrin (porfimer sodium) & photodynamic therapy.
3 Recruiting A Study of the Specificity and Sensitivity of 5- Aminolevulinic Acid (ALA) Fluorescence in Malignant Brain Tumors
Condition: Brain Neoplasms
Intervention: Drug: Tumor fluorescence
4 Not yet recruiting A Drug Study to Determine the Long-term Safety and Tolerability in Children and Adolescents (4-17 Years in Age) Taking the Drug
Condition: Epilepsy
Intervention: Drug: Eslicarbazepine acetate
5 Not yet recruiting Fentanyl Sublingual Spray for the Treatment of Acute Procedure-related Pain in a Monitored Setting
Condition: Chronic Pain
Interventions: Drug: Fentanyl Sublingual Spray (FSS);   Drug: Placebo Sublingual Spray (PSS)
6 Recruiting Ataluren for Nonsense Mutation in CDKL5 and Dravet Syndrome
Condition: Epilepsy
Interventions: Drug: ataluren;   Drug: Placebo
7 Recruiting Safety and Efficacy Study of Hydromorphone Hydrochloride by Intrathecal Administration Using a Programmable Implantable Pump
Condition: Management of Chronic Pain
Intervention: Drug: Hydromorphone Hydrochloride
8 Recruiting Repeat-Dose Pharmacokinetics Study of NRL-1 in Epilepsy Subjects
Condition: Acute Repetitive Seizures
Intervention: Drug: NRL-1
9 Recruiting Open-Label Safety and PK Study of ER Hydromorphone Tablets in Opioid-Tolerant Pediatric Chronic Pain Patients
Condition: Chronic Pain
Intervention: Drug: Hydromorphone HCl ER Tablets
10 Recruiting Safety Study of Afatinib for Brain Cancer
Condition: Brain Cancer
Intervention: Drug: Afatinib
11 Recruiting Medium Chain Triglycerides as an Adjunct to the Modified Atkins Diet for Women With Catamenial Epilepsy
Conditions: Epilepsy;   Seizure;   Catamenial Epilepsy;   Medically Resistant Epilepsy;   Medically Resistant Seizures
Intervention: Dietary Supplement: betaquik®
12 Recruiting Photodynamic Therapy (PDT) For Recurrent High Grade Gliomas
Condition: Brain Tumor, Recurrent
Intervention: Drug: Photofrin photodynamic therapy.
13 Recruiting Diagnostic Performance of Fluorescein as an Intraoperative Brain Tumor Biomarker
Condition: Brain Cancer
Interventions: Drug: Fluorescein;   Drug: Fluorescein + ALA
14 Recruiting Open-label Study to Evaluate Long-term Safety and Efficacy of SPN-812 Extended Release (ER)
Condition: Attention Deficit Hyperactivity Disorder
Intervention: Drug: SPN-812 ER
15 Recruiting Study of the IDO Pathway Inhibitor, Indoximod, and Temozolomide for Pediatric Patients With Progressive Primary Malignant Brain Tumors
Conditions: Glioblastoma Multiforme;   Glioma;   Gliosarcoma;   Malignant Brain Tumor;   Ependymoma;   Medulloblastoma
Interventions: Drug: Indoximod;   Drug: Temozolomide;   Radiation: Conformal Radiation
16 Recruiting Treatment of Impulsive Aggression in Subjects With ADHD in Conjunction With Standard ADHD Treatment (CHIME 4)
Condition: Attention Deficit Hyperactivity Disorder (ADHD)
Intervention: Drug: SPN-810
17 Recruiting A Study to Assess the Efficacy and Safety of Brivaracetam as Treatment for Increased Seizure Activity in an Epilepsy Monitoring Unit Setting
Condition: Epilepsy
Interventions: Drug: Brivaracetam;   Drug: Lorazepam
18 Recruiting Shire SCT: Lisdexamfetamine Treatment for ADHD and SCT
Conditions: Attention Deficit Disorder;   Attention Deficit Hyperactivity Disorder
Interventions: Drug: Lisdexamfetamine;   Drug: Placebo
19 Recruiting Education Interventions for Self-Management of Pain Post-SCI: A Pilot Study
Conditions: Spinal Cord Injury;   Chronic Pain
Interventions: Other: Education Program Type 1;   Other: Education Program Type 2
20 Recruiting Trial of Nivolumab With Radiation or Nivolumab and Ipilimumab With Radiation for the Treatment of Intracranial Metastases From Non-Small Cell Lung Cancer
Condition: Metastatic Brain Cancer
Interventions: Drug: Nivolumab;   Drug: Ipilimumab;   Radiation: Stereotactic Radiosurgery (SRS);   Radiation: Whole Brain Radiation Therapy (WBRT);   Behavioral: Neurocognitive Exam

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.